Free Trial
LON:VEC

Vectura Group (VEC) Share Price, News & Analysis

Vectura Group logo

About Vectura Group Stock (LON:VEC)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
164.80
164.80
52-Week Range
N/A
Volume
203,761 shs
Average Volume
3.37 million shs
Market Capitalization
£1.01 billion
P/E Ratio
8.20
Dividend Yield
23.06%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri, Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta, Anoro Ellipta, and Trelegy Ellipta for the treatment of COPD. It is also developing VR315 (US) for the treatment of asthma and COPD.In addition, the company offers dry powder inhalers, pressurized metered dose inhalers, and nebulized devices. Vectura Group plc was founded in 1997 and is headquartered in Chippenham, the United Kingdom.

Remove Ads
Receive VEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vectura Group and its competitors with MarketBeat's FREE daily newsletter.

VEC Stock News Headlines

Trump… a socialist?
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

VEC Stock Analysis - Frequently Asked Questions

Shares of VEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vectura Group investors own include Hikma Pharmaceuticals (HIK), SEB (SKP), BTG (BTG), iRobot (IRBT), Sinclair Pharma (SPH), Sirius Minerals (SXX) and Taylor Wimpey (TW).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Current Symbol
LON:VEC
CIK
N/A
Fax
N/A
Employees
9,200
Year Founded
N/A

Profitability

Trailing P/E Ratio
8.20
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£190.60 million
Price / Cash Flow
12.48
Book Value
GBX 91.70 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
£1.01 billion
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (LON:VEC) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners